Failure of montelukast to prevent anaphylaxis to diclofenac.
Enrique
E
E
Allergy Unit, Hospital Universitari Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain.
García-Ortega
P
P
Gaig
P
P
San Miguel
M M
MM
D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced* / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D003521:Cyclopropanes; D004008:Diclofenac / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008297:Male; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides; D017211:Treatment Failure
D000085:Acetates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D004008:Diclofenac; C093875:montelukast; D001241:Aspirin